Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Announcing a new publication for Acta Materia Medica journal. The binding affinity of aptamers to targets has a crucial role in the pharmaceutical and biosensing effects. Despite diverse ...

Rahul Saluja, Senior Executive and Thought Leader in Life Sciences.

Sruthi Potru demonstrates that machine learning is not just enhancing data quality management it's fundamentally transforming ...

The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Research & ...

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...

This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing ...

Despite diverse post-systematic evolution of ligands by exponential enrichment (post-SELEX) modifications explored in aptamer optimization, accurate prediction of high-affinity modification strategies ...

The global humidity sensor market is expected to be valued at USD 3.44 billion in 2025 and is projected to reach USD 4.64 billion by 2030; ...

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

Regional Analysis: North America holds 40% of the Generative AI Life Sciences market... Lawrence John Prudour +91 91308 55334 ...